Group III metabotropic glutamate receptor activation inhibits Ca2+ influx and nitric oxide synthase activity in bone marrow stromal cells
- 29 March 2005
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (2) , 704-713
Abstract
Nitric oxide (NO) is pivotal to bone physiology. In the central nervous system constitutive, Ca2+‐calmodulin regulated NO synthase activity and glutamate signalling are intimately linked. Since L‐glutamate signalling occurs in bone and is implicated in bone regulation, we have investigated the effect of L‐glutamate on NO synthase in bone‐derived cells. Treatment of marrow stromal cells with L‐glutamate reduced basal NO synthase activity by 40%. Imaging showed that L‐glutamate caused a rapid, usually localised and slowly‐reversible fall in [Ca2+]i. This effect was resistant to disruption of intracellular Ca2+ stores but sensitive to extracellular La3+ or omission of extracellular Ca2+, demonstrating that glutamate acts by inhibition of membrane Ca2+ influx. The only previous description of such an effect of L‐glutamate is via activation of the group III receptor, mGluR6, in the retina. Using Western blotting and RT‐PCR we detected mGluR6 protein and transcripts in marrow stromal cells. The effects of L‐glutamate on NOS activity and [Ca2+]i in marrow stromal cells were abolished by a group III mGluR inhibitor, (S)‐2‐amino‐2‐methyl‐4‐phosphonobutyric acid. Recording of membrane potential showed that, similarly to the effects of retinal mGluR6 activation, L‐glutamate induced membrane hyperpolarisation (−16 ± 2 mV), which was also sensitive to group III mGluR inhibition. L‐glutamate had no effect on cAMP levels. We conclude that activation of a group III mGluR in bone marrow stromal cells inhibits a Ca2+‐permeable plasma membrane channel, reducing [Ca2+]i and suppressing generation of NO. These observations directly link bone L‐glutamate signalling to processes central to bone growth and regulation.Keywords
This publication has 64 references indexed in Scilit:
- Modulation of cellular differentiation by N ‐methyl‐ d ‐aspartate receptors in osteoblastsThe FASEB Journal, 2003
- Nitric oxide and boneImmunology, 2001
- Group III Metabotropic Glutamate Receptors in Rat Cultured Calvarial OsteoblastsBiochemical and Biophysical Research Communications, 2001
- Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and ActivityThe American Journal of Pathology, 2001
- Mechanical Strain Stimulates Nitric Oxide Production by Rapid Activation of Endothelial Nitric Oxide Synthase in OsteocytesJournal of Bone and Mineral Research, 1999
- Nitric Oxide Synthase Expression in Bone CellsBone, 1998
- Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents?Bone, 1997
- Pulsating Fluid Flow Increases Nitric Oxide (NO) Synthesis by Osteocytes but Not Periosteal Fibroblasts - Correlation with Prostaglandin UpregulationBiochemical and Biophysical Research Communications, 1995
- Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypesNeuropharmacology, 1995
- Temporal and Depolarization‐Induced Changes in the Absolute Amounts of mRNAs Encoding Metabotropic Glutamate Receptors in Cerebellar Granule Neurons In VitroJournal of Neurochemistry, 1994